Forbes January 8, 2026
Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week and could change obesity care. Here’s how the Wegovy pill works, who qualifies, how to take it, side effects, cost, and what this means for treatment now.
Novo Nordisk has launched the Wegovy weight loss pill in the United States, removing one of the biggest barriers that has limited GLP-1 weight loss treatment – injections.
I see this hesitation regularly in clinic. Patients who qualify for GLP-1 therapy, understand the benefits, and want to lose weight still decline treatment because they do not want weekly injections. The pill does not change the biology. It changes the decision point.
The Wegovy pill contains the same active ingredient as injectable Wegovy,...







